Bluebird bio has rebranded to Genetix Biotherapeutics, marking a new chapter for the company that was once a frontrunner in ...

FUJIFILM Biotechnologies is expanding its global partnership with argenx to manufacture the latter’s drug substance for ...

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken ...

The main concerns about tariffs that businesses have are higher input costs and uncertainty in long-term planning.

After four years of inactivity, the US Food and Drug Administration (FDA) approved three novel products for hereditary ...

The postpartum depression marketing authorisation in the EU follows approvals for the drug in the US and the UK over the past ...

China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop new siRNA candidate, ...

Annual Meeting 2025, findings were shown from the Phase IIIa REDEFINE 2 trial, assessing Novo Nordisk’s fixed-dose ...

At the 2025 European Association for the Study of Diabetes (EASD) meeting in Vienna, SAB Biotherapeutics presented Phase 1 ...

Annual Meeting 2025, findings from a Phase II clinical trial of NA-931 were presented. The study evaluated the weight-loss ...

The API and drug product facility is the first of four new manufacturing plants set to be built by Eli Lilly in the US over ...

Annual Meeting 2025, held from August 29 to September 1 in Madrid, Spain, showcased a sweeping array of advancements in the ...